Yelak Biru was diagnosed with multiple myeloma at 25 and given just a few years to live. Thirty years later, he's thriving.

A study looked at the best ways researchers can approach clinical trials on social media to encourage more people to sign up.

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Living with TD? Let’s dive into the top five leading therapies for tardive dyskinesia you’ve probably never even heard ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

According to new data, a staggering 74% of colorectal cancer patients struggle to find someone who understands what they’re ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Autoimmune disease symptoms vary greatly depending on which part of the body is affected, but some common symptoms include ...

These could be signs of hepatic encephalopathy, often shortened to HE—a serious but often misunderstood complication of liver ...

Emerging research is uncovering how a fiber-rich, whole-foods-based diet may help support better outcomes for patients ...

Nucala's approval offers hope for uncontrolled COPD. This new drug reduces flare-ups, a key benefit for Black Americans.

Dr. Kameelah Phillips shares the importance of empowerment and what women can do take control of their health and bodies.